← BELITE BIO, INC
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Net Income From Continuing Operations | — | ($9.7m) | ($12.6m) | ($31.6m) | ($36.1m) | ($77.6m) | ($77.6m) | |
| Net loss | ($5.8m) | ($9.7m) | ($12.6m) | ($31.6m) | ($36.1m) | ($77.6m) | — | |
| Depreciation | $17k | $30k | $64k | $139k | $164k | $172k | $452k | |
| Amortization of Intangible Assets | — | — | — | — | $4k | $12k | — | |
| Amortization Cash Flow | — | — | $0 | $0 | $4k | $12k | — | |
| Amortization Of Intangibles | — | — | $0 | $0 | $4k | $12k | $12k | |
| Depreciation Amortization Depletion | — | — | $198k | $399k | $449k | $464k | $464k | |
| Share-based Payment Arrangement, Noncash Expense | — | $1.5m | $1.5m | $3.8m | $9.0m | $38.9m | $38.9m | |
| Share-based Payment Arrangement, Expense | — | $1.5m | $1.5m | $3.8m | $9.0m | — | $38.9m | |
| Share-based compensation expense | $1.4m | $1.5m | $1.5m | $3.8m | $9.0m | $38.9m | $38.9m | |
| Other Nonoperating Income (Expense) | — | $126k | $166k | ($4k) | $141k | ($41k) | — | |
| Nonoperating Income (Expense) | — | $131k | $173k | $45k | $3.9m | $6.6m | — | |
| Change In Working Capital | — | — | ($491k) | ($2.4m) | $1.1m | $2.6m | $2.6m | |
| Other receivables | — | — | — | ($56k) | $56k | ($66k) | — | |
| Other receivables due from related parties | $4k | — | ($32k) | ($16k) | $18k | — | — | |
| Change In Receivables | — | — | ($32k) | ($72k) | $74k | ($66k) | ($66k) | |
| Other payables due to related parties | ($19k) | $45k | ($41k) | — | $13k | ($8k) | — | |
| Change In Payables And Accrued Expense | — | — | $332k | $1.4m | $2.5m | $3.8m | ($8k) | |
| Accrued expenses and other liabilities | ($254k) | $632k | $373k | $1.4m | $2.5m | $3.8m | — | |
| Change In Accrued Expense | — | — | $373k | $1.4m | $2.5m | $3.8m | $3.8m | |
| Prepayments and other assets | — | — | — | ($3.5m) | ($1.1m) | ($768k) | — | |
| Change In Other Current Liabilities | — | — | ($71k) | ($244k) | ($305k) | ($301k) | ($301k) | |
| Net Cash Provided by (Used in) Operating Activities | ($4.4m) |
($7.5m)
-68.26%
|
($11.5m)
-53.30%
|
($29.8m)
-160.40%
|
($29.2m)
+2.02%
|
($37.0m)
-26.52%
|
($37.0m)
0.00%
|
|
| Cash flows from investing activities: | ||||||||
| Gain (Loss) on Disposition of Property Plant Equipment | ($20k) | $8k | ($394k) | ($63k) | ($116k) | ($107k) | — | |
| Payments to Acquire Property, Plant, and Equipment | — | $74k | $394k | $63k | $116k | $71k | ($178k) | |
| Unrealized Gain (Loss) on Investments | — | — | — | — | $49k | — | $0 | |
| Interest income from investments | — | — | — | — | ($3.6m) | ($1.3m) | — | |
| Acquisition of held-to-maturity investments | — | — | — | — | ($183.8m) | ($452.0m) | — | |
| Proceeds from maturities of held-to-maturity investments | — | — | — | — | $77.8m | $142.6m | — | |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | — | — | — | — | — | $4.5m | — | |
| Net Cash Provided by (Used in) Investing Activities | ($20k) | ($56k) | ($394k) | ($63k) | ($110.6m) | ($305.1m) | ($305.1m) | |
| Cash flows from financing activities: | ||||||||
| Issuance Of Debt | — | $0 | $0 | — | — | — | $0 | |
| Long Term Debt Issuance | — | $0 | $0 | — | — | — | $0 | |
| Net Issuance Payments Of Debt | — | $0 | $0 | — | — | — | $0 | |
| Long Term Debt Payments | — | $0 | $0 | — | — | — | $0 | |
| Repayment Of Debt | — | $0 | $0 | — | — | — | $0 | |
| Issuance Of Capital Stock | — | — | $38.0m | $55.2m | $42.2m | $182.0m | $182.0m | |
| Common Stock Issuance | — | — | $38.0m | $55.2m | $42.2m | $182.0m | $182.0m | |
| Dividends Payable | — | — | $0 | $0 | $0 | $0 | — | |
| Net Other Financing Charges | — | — | ($1.0m) | ($1.2m) | ($368k) | $370.4m | $370.4m | |
| Net Cash Provided by (Used in) Financing Activities | — | ($583k) |
$37.0m
+6440.14%
|
$76.0m
+105.50%
|
$83.6m
+10.05%
|
$663.2m
+693.39%
|
$663.2m
0.00%
|
|
| NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENT | $23.6m | ($8.3m) | $24.7m | $46.1m | ($56.5m) | $321.3m | ||
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | ($8.3m) | $24.7m | $46.1m | ($56.5m) | $321.3m | $352.9m | |
| Beginning Cash Position | — | — | $17.3m | $42.1m | $88.2m | $31.7m | $31.7m | |
| CASH AND CASH EQUIVALENT AT BEGINNING OF THE YEAR | $25.6m | $17.3m | $42.1m | $88.2m | $31.7m | $352.9m | ||
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | ($161k) | ($366k) | $9k | ($269k) | $117k | $117k | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | $17.3m | $42.1m | $88.2m | $31.7m | $352.9m | $352.9m | |
| Effects of exchange rate on cash and cash equivalent | $4k | ($161k) | ($366k) | $9k | ($269k) | $117k | — | |
| Effect Of Exchange Rate Changes | — | — | ($366k) | $9k | ($269k) | $117k | $117k | |
| Additional Supplementary Disclosures | ||||||||
| Additional Supplementary Disclosures | ||||||||
| Income Tax Expense (Benefit) | — | — | $0 | $9k | $6k | $0 | — | |
| Interest Expense Nonoperating | — | — | — | — | $20k | $2k | — | |
| Operating lease liabilities | — | — | ($71k) | ($244k) | ($305k) | ($301k) | — | |
| Right-of-use assets in exchange of lease liabilities from an operating lease modification | — | — | — | — | $385k | $361k | — | |
| Additional Financial Items | ||||||||
| Proceeds from Stock Options Exercised | — | $232k | $3k | $349k | $2.8m | $7.8m | — | |
| General and Administrative Expense | — | $2.4m | $4.0m | $6.8m | $10.1m | — | — | |
| Investment Income, Interest | — | $5k | $23k | $74k | $3.7m | $6.6m | — | |
| Operating Expenses | — | $9.8m | $12.8m | $31.7m | $40.0m | $84.2m | — | |
| Non-cash lease expense | — | $0 | $134k | $260k | $281k | $280k | — | |
| Security deposits | $8k | ($2k) | ($79k) | ($16k) | — | ($150k) | — | |
| Payments of deferred offering costs | — | ($815k) | ($1.0m) | ($1.2m) | ($368k) | ($8.0m) | — | |
| Net proceeds from issuance | $500k | — | — | $55.2m | $41.5m | $154.0m | — | |
| Proceeds from offering | — | — | — | — | $25.0m | $406.4m | — | |
| Proceeds from exercise of warrants | — | — | — | $21.7m | $39.0m | $103.0m | — | |
| Proceeds from exercise of share options | $86k | $232k | $3k | $349k | $2.8m | $7.8m | — | |
| ATM offering sales commissions reclassed to additional paid-in-capital | — | — | — | $858k | $509k | $896k | — | |
| Right-of-use assets obtained in exchange of lease liabilities | — | — | $941k | $265k | $388k | $529k | — | |
| Cash Flow From Continuing Financing Activities | — | — | $37.0m | $76.0m | $83.6m | $663.2m | $663.2m | |
| Cash Flow From Continuing Investing Activities | — | — | ($394k) | ($63k) | ($110.6m) | ($305.1m) | ($305.1m) | |
| Change In Payable | — | $45k | ($41k) | — | $13k | ($8k) | ($8k) | |
| Change In Prepaid Assets | — | — | ($720k) | ($3.5m) | ($1.1m) | ($918k) | ($918k) | |
| Changes In Cash | — | — | $25.1m | $46.1m | ($56.2m) | $321.1m | $321.1m | |
| End Cash Position | — | — | $42.1m | $88.2m | $31.7m | $352.9m | $352.9m | |
| Financing Cash Flow | — | — | $37.0m |
$76.0m
+105.50%
|
$83.6m
+10.05%
|
$663.2m
+693.39%
|
$663.2m
0.00%
|
|
| Free Cash Flow | — | — | ($11.9m) | ($29.9m) | ($29.4m) | ($37.2m) | ($37.2m) | |
| Gain Loss On Sale Of PPE | — | ($8k) | $0 | $0 | — | — | $0 | |
| Investing Cash Flow | — | — | ($394k) | ($63k) | ($110.6m) | ($305.1m) | ($305.1m) | |
| Net Intangibles Purchase And Sale | — | — | $0 | $0 | ($35k) | $0 | $0 | |
| Net PPE Purchase And Sale | — | — | ($394k) | ($63k) | ($116k) | ($178k) | ($178k) | |
| Net Preferred Stock Issuance | — | $0 | $0 | — | — | — | $0 | |
| Other Non Cash Items | — | — | — | — | ($3.6m) | ($1.3m) | — | |
| Proceeds From Stock Option Exercised | — | — | $3k | $22.0m | $41.7m | $110.8m | $110.8m | |
| Purchase Of Intangibles | — | — | $0 | $0 | ($35k) | $0 | $0 | |
| Purchase Of PPE | — | — | ($394k) | ($63k) | ($116k) | ($178k) | ($178k) | |
| Sale Of PPE | — | $18k | $0 | $0 | — | — | $0 | |
| Stock Based Compensation | — | — | $1.5m | $3.8m | $9.0m | $38.9m | $38.9m | |
| Unrealized Gain Loss On Investment Securities | — | — | $0 | $0 | ($49k) | $0 | $0 | |
| Net Investment Purchase And Sale | — | — | $0 | $0 | ($110.4m) | ($304.9m) | ($304.9m) | |
| Purchase Of Investment | — | — | $0 | $0 | ($188.3m) | ($452.0m) | ($452.0m) | |
| Sale Of Investment | — | — | $0 | $0 | $77.8m | $147.1m | $147.1m | |
| Supplemental disclosure of cash flow information: | ||||||||
| Change In Cash Supplemental As Reported | — | — | $24.7m | $46.1m | ($56.5m) | $321.3m | — | |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $19k | — | $16k | $0 | $0 | $1k | — |